Close the transaction to combine Mylan with Upjohn
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 29 Jul 2019
- Due
- 30 Jun 2020
- Checked
- 1 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The transaction is anticipated to close in mid-2020, subject to approval by Mylan shareholders and customary closing conditions, including receipt of regulatory approvals.”
What we found
Evidence strength A What the grades mean
The company failed to close the transaction by the mid-2020 deadline, with filings from August 2020 stating the expected closing date had been pushed to the fourth quarter of 2020.
-
A Pfizer Inc. 8-K filed 2020-07-28
“Pfizer and Mylan expect the transaction to be completed in fourth-quarter 2020.” ✓ confirmed on the page
-
A Pfizer Inc. 10-Q filed 2020-08-06
“The transaction was approved by Mylan’s shareholders in June 2020 and is anticipated to close in the fourth quarter of 2020” ✓ confirmed on the page
Market reaction: the shares moved +4.0% against the S&P 500 over the three sessions around the disclosure (27 Jul 2020 to 30 Jul 2020). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Mylan and Upjohn combination
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: approval by Mylan shareholders; customary closing conditions; receipt of regulatory approvals
- Depends on
- Regulatory, Shareholder
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Pfizer Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2019-PFE-001538 · Corrections policy